Drug Type Synthetic peptide |
Synonyms HM-201 |
Target |
Mechanism ADMR agonists(Adrenomedullin receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Himuka AM Pharma Corp.Startup |
Active Organization Himuka AM Pharma Corp.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 2 | JP | Himuka AM Pharma Corp.Startup | 29 Oct 2021 |